Cephalotaxus esters, methods of synthesis, and uses thereof
US9006231B2 · kind B2 · utility
0Cited by
10References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2013 |
| Grant date | Apr 14, 2015 |
| Priority date | — |
| Expiry date | Jun 18, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel cephalotaxus esters, syntheses thereof, and intermediates thereto. The invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of using said compounds or compositions in the treatment of proliferative diseases (e.g., benign neoplasm, cancer, inflammatory disease, autoimmune disease, diabetic retinopathy) and infectious disease. The invention further provides methods of using said compounds or compositions in the treatment of multidrug resistant cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.